Benzinga's Top Pre-Market Losers

Impax Laboratories

dipped 21.00% to $15.80 in the pre-market session. Impax Laboratories reported that the FDA completed its re-inspection of its Hayward manufacturing facility. At the conclusion of this inspection, the FDA issued a new Form 483 with 12 observations. Hospira

shares dropped 4.10% to $28.55 in pre-market trading. Hospira's trailing-twelve-month ROE is 1.48%. J.C. Penney Co

shares fell 3.82% to $16.10 in the pre-market trading on reports that a stakeholder is selling a large block of shares in the retailer. Weyerhaeuser Co

dipped 3.17% to $29.00 in the pre-market session. Weyerhaeuser's PEG ratio is 5.65.